Recruiting Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) NCT06773026 Conditions Medium chain acyl CoA dehydrogenase deficiency, Medium-chain Acyl-CoA Dehydrogenase Deficiency Locations UPMC Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States View Trial Details
Recruiting Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals NCT06623032 Conditions Medium chain acyl CoA dehydrogenase deficiency, Medium-chain Acyl-CoA Dehydrogenase Deficiency Locations University of Copenhagen — Copenhagen, Denmark View Trial Details
Completed Fatty Acid Oxidation Defects and Insulin Sensitivity NCT02517307 Conditions Carnitine Palmitoyltransferase II Deficiency, Late-Onset, Carnitine Palmitoyltransferase II Deficiency, Myopathic, Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency, +7 more Locations Oregon Health & Science University — Portland, Oregon, United States View Trial Details
Active, Not Recruiting Early Check: Expanded Screening in Newborns NCT03655223 Conditions 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more Locations RTI International — Research Triangle Park, North Carolina, United States View Trial Details
